Abstract
Osteoporosis is a condition of reduced bone density and increased susceptibility to fractures without abnormal mineralization of bone matrix.1 The World Health Organization (WHO) defines osteoporosis as the presence of a bone mineral density (BMD) at least 2.5 standard deviations below the mean BMD for young adults.2 Osteoporosis affects an estimated 20 million to 25 million people in the United States, particularly postmenopausal women and the elderly of both sexes.3 Its most common serious manifestations are fractures of the hip, forearm, and vertebrae. Measures taken at several critical periods during the life cycle, especially childhood, the climacteric, and old age, have the potential to prevent osteoporotic fractures. Therefore family physicians are in a key position for preventing and treating this disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Consensus Development Conference. Prophylaxis and treatment of osteoporosis. Am J Med 1991;90:107–10.
World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group. WHO Techn Rep Ser 1994;No. 843:1–6.
Nevitt MC. Epidemiology of osteoporosis. Rheum Dis Clin North Am 1994;20:535–59.
Lufkin EG, Zilkoski M. Diagnosis and management of osteoporosis. American Academy of Family Physicians, Kansas City, MO: American Academy of Family Physicians, 1996. American Family Physician Monograph No. 1.
Mundy GR. Peptides and growth regulatory factors in bone. Rheum Dis Clin North Am 1994;20:577–88.
Jackson JA, Kleerekoper M. Osteoporosis in men: diagnosis, pathophysiology, and prevention. Medicine (Baltimore) 1990; 69:137–52.
Christiansen C, editor. Proceedings of a symposium: consensus development conference on osteoporosis. Am J Med 1991;91 Suppl 5B:1S-68S.
Melton LJ III, Eddy DM, Johnston CC Jr. Screening for osteoporosis. Ann Intern Med 1990;112:516–28.
Breslau NA. Calcium, estrogen, and progestin in the treatment of osteoporosis. Rheum Dis Clin North Am 1994;20: 691–716.
Committee on Nutritional Status During Pregnancy and Lactation, Institute of Medicine, National Academy of Sciences. Nutrition during pregnancy. Washington, DC: National Academy Press, 1990:318–35.
Committee on Nutritional Status During Pregnancy and Lactation, Institute of Medicine, National Academy of Sciences. Nutrition during lactation. Washington, DC: National Academy Press, 1991:204–6.
Licata AA. Therapies for symptomatic primary osteoporosis. Geriatrics 1991;46:62–7.
Wishart JM, Need AG, Horowitz M, et al. Effect of age on bone density and bone turnover in men. Clin Endocrinol (Oxf) 1995;42:141–6.
Orwoll ES, Bliziotes M. Heterogeneity in osteoporosis. Rheum Dis Clin North Am 1994;20:671–83.
Banas MP, Kaplan FS, Fallon MD, Haddad JG. Regional migratory osteoporosis: a case report and review of the literature. Clin Orthop 1990;250:303–9.
Bauer RL. Assessing osteoporosis. Hosp Pract 1991;26 Suppl 1:23–9.
Bouxsein ML, Marcus R. Overview of exercise and bone mass. Rheum Dis Clin North Am 1994;20:787–99.
Prince RL, Smith M, Dick IM, et al. Prevention of postmenopausal osteoporosis: a comparative study of exercise, calcium supplementation, and hormone-replacement therapy N Engl J Med 1991;325:1189–95.
Grisso JA, Attie M. Prevention of osteoporotic fractures. In: Lavizzo-Mourey R, Day S, Diserens D, Grisso JA, editors. Practicing prevention for the elderly. Philadelphia: Hanley & Belfus, 1989:107–23.
US Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore: Williams & Wilkins, 1996: 509–16, 829–43.
Patel U, Skingle S, Campbell GA, Crisp AJ, Boyle IT. Clinical profile of acute vertebral compression fractures in osteoporosis. Br J Rheumatol 1991;30:418–21.
Rifat SF, Kiningham RB, Peggs JF. Calcitonin in the treatment of osteoporotic bone pain. J Fam Pract 1992;35:93–6.
Avioli LV. Calcitonin therapy in osteoporotic syndromes. Rheum Dis Clin North Am 1994;20:777–85.
Taylor AK, Lueken SA, Libanata C, Baylin DJ. Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Rheum Dis Clin North Am 1994;20:589–605.
Hagiwara S, Yang S, Gluer CC, Bendavid E, Genant HK. Noninvasive bone mineral density measurement in the evaluation of osteoporosis. Rheum Dis Clin North Am 1994; 20:651–65.
National Osteoporosis Foundation. Bone densitometry and its use in the diagnosis of osteoporosis. Osteoporosis Clin Updates 1996; l (3):l–4.
DATTA: diagnostic and therapeutic technology assessment: measurement of bone density with dual-energy x-ray absorptiometry (DEXA). JAMA 1992; 267: 286–94.
Preventing and treating osteoporosis: what every woman needs to know. Older Women’s League (OWL), 666 11th Street NW, Suite 700, Washington, DC 20001,1994:1–20. Women’s Health Education Series.
Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. N Engl J Med 1995;332: 767–73.
Cummings SR, Browner WS, Ettinger B. Should prescription of postmenopausal hormone therapy be based on the results of bone densitometry? Ann Intern Med 1990;113:565–7.
Stampfer MJ, Colditz G A. Estrogen replacement therapy and coronary artery disease: a quantitative review of the epidemiologic evidence. Prev Med 1991;20:47–63.
Rubin SM, Cummings SR. Results of bone densitometry affect women’s decisions about taking measures to prevent fractures. Ann Intern Med 1992;116:990–5.
Ryan PJ, Harrison R, Blake GM, et al. Compliance with hormone replacement therapy (HRT) after screening for postmenopausal osteoporosis. Br J Obstet Gynaecol 1992;99: 325–8.
Riggs BL, Melton LJ III. The prevention and treatment of osteoporosis. N Engl J Med 1992;327:620–7.
Optimal calcium intake. NIH consensus statement. 1994, June 6–8;12(4):l-31.
Calcium supplements. Med Lett 1989;31:101–3.
Laitinen K, Lamberg-Allardt C, Tunninen R, et al. Bone mineral density and abstention-induced changes in bone and mineral metabolism in noncirrhotic male alcoholics. Am J Med 1992;93:642–50.
Love RR, Mazess RB, Barden HS, et al. Effects of tamoxifen on bone mineral content in postmenopausal women with breast cancer. N Engl J Med 1992;326:852–6.
Ettinger B, Grady D. Maximizing the benefit of estrogen therapy for prevention of osteoporosis. Menopause 1994; 1:19–24.
Watts NB. Treatment of osteoporosis with bisphosphonates. Rheum Dis Clin North Am 1994;20:717–31.
Liberman UA, Weiss SR, Broil J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl Med 1995;333:1437–43.
Wimalawansa SJ. Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study. Am J Med 1995;99:36–42.
Tilyard MW, Spears GFS, Thomson J, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992;326:357–62.
Bikle DD. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis. Rheum Dis Clin North Am 1994;20:759–75.
Kimmel DB, Slovik DM, Lane NE. Current and investigational approaches for reversing established osteoporosis. Rheum Dis Clin North Am 1994;20:735–50.
Riggs BL, Hodgson SF, O’Fallon WM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990;322:802–9.
Pak CY, Adams-Huet B, Piziak V, et al. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride: final report of a randomized controlled trial. Ann Intern Med 1995;123:401–8.
Sebert JL, Richard P, Mennecier I, et al. Monofluorophosphate increases lumbar bone density in osteopenic patients: a double-masked randomized study. Osteoporos Int 1995;5:108–14.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Acheson, L.S., Stange, K.C. (1998). Osteoporosis. In: Taylor, R.B., David, A.K., Johnson, T.A., Phillips, D.M., Scherger, J.E. (eds) Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-2947-4_122
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2947-4_122
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-2949-8
Online ISBN: 978-1-4757-2947-4
eBook Packages: Springer Book Archive